Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology

被引:27
作者
Zehbe, Ingeborg [1 ,2 ,3 ]
Jackson, Robert [1 ,4 ]
Wood, Brianne [5 ]
Weaver, Bruce [3 ]
Escott, Nicholas [3 ,6 ]
Severini, Alberto [7 ]
Krajden, Mel [8 ]
Bishop, Lisa [2 ]
Morrisseau, Kyla [2 ]
Ogilvie, Gina [8 ,9 ]
Burchell, Ann N. [10 ,11 ]
Little, Julian [5 ]
机构
[1] Thunder Bay Reg Res Inst, Probe Dev & Biomarker Explorat, Thunder Bay, ON, Canada
[2] Lakehead Univ, Dept Biol, Thunder Bay, ON, Canada
[3] Northern Ontario Sch Med, Clin Sci, Thunder Bay, ON, Canada
[4] Lakehead Univ, Biotechnol Program, Thunder Bay, ON, Canada
[5] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada
[6] Thunder Bay Reg Hlth Sci Ctr, Dept Pathol & Lab Med, Thunder Bay, ON, Canada
[7] Publ Hlth Agcy Canada, Viral Exanthemata & STD Sect, Natl Microbiol Lab, Winnipeg, MB, Canada
[8] BC Ctr Dis Control, Vancouver, BC, Canada
[9] Univ British Columbia, Sch Populat & Publ Hlth, Fac Med, Vancouver, BC, Canada
[10] Ontario HIV Treatment Network, Toronto, ON, Canada
[11] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
来源
BMJ OPEN | 2016年 / 6卷 / 10期
基金
加拿大健康研究院;
关键词
TO-TREAT ANALYSIS; 1ST NATIONS; NEW-ZEALAND; WOMEN; HPV; STATEMENT; CANADA; INTERVENTION; INDIVIDUALS; AUSTRALIA;
D O I
10.1136/bmjopen-2016-011754
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The incidence of cervical cancer is up to 20-fold higher among First Nations women in Canada than the general population, probably due to lower participation in screening. Offering human papillomavirus (HPV) self-sampling in place of Papanicolaou (Pap) testing may eventually increase screening participation and reduce cervical cancer rates in this population. Design: A community-randomised controlled screening trial. Setting: First Nations communities in Northwest Ontario, Canada. Participants: Women aged between 25 and 69, living in Robinson Superior Treaty First Nations. The community was the unit of randomisation. Interventions: Women were asked to complete a questionnaire and have screening by HPV self-sampling (arm A) or Pap testing (arm B). Primary outcome measures: The number of women who participated in cervical screening. Randomisation: Community clusters were randomised to include approximately equivalent numbers of women in each arm. Results: 6 communities were randomised to arm A and 5 to arm B. One community withdrew, leaving 5 communities in each group (834 eligible women). Participation was <25%. Using clustered intention-to-treat (ITT) analysis, initial and cumulative averaged uptakes in arm A were 1.4-fold (20% vs 14.3%, p=0.628) and 1.3-fold (20.6% vs 16%, p=0.694) higher compared to arm B, respectively. Corresponding per protocol (PP) analysis indicates 2.2-fold (22.9% vs 10.6%, p=0.305) and 1.6-fold (22.9% vs 14.1%, p=0.448) higher uptakes in arm A compared to arm B. Screening uptake varied between communities (range 0-62.1%). Among women who completed a questionnaire (18.3% in arm A, 21.7% in arm B), the screening uptake was 1.8-fold (ITT; p=0.1132) or 3-fold (PP; p<0.01) higher in arm A versus arm B. Conclusions: Pap and HPV self-sampling were compared in a marginalised, Canadian population. Results indicated a preference for self-sampling. More research on how to reach underscreened Indigenous women is necessary.
引用
收藏
页数:11
相关论文
共 43 条
  • [1] Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial
    Arrossi, Silvina
    Thouyaret, Laura
    Herrero, Rolando
    Campanera, Alicia
    Magdaleno, Adriana
    Cuberli, Milca
    Barletta, Paula
    Laudi, Rosa
    Orellana, Liliana
    [J]. LANCET GLOBAL HEALTH, 2015, 3 (02): : E85 - E94
  • [2] Campbell I, 2007, STAT MED, V26, P3661, DOI 10.1002/sim.2832
  • [3] Consort 2010 statement: extension to cluster randomised trials
    Campbell, Marion K.
    Piaggio, Gilda
    Elbourne, Diana R.
    Altman, Douglas G.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
  • [4] CONSORT statement: extension to cluster randomised trials
    Campbell, MK
    Elbourne, DR
    Altman, DG
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7441): : 702 - 708
  • [5] SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
    Chan, An-Wen
    Tetzlaff, Jennifer M.
    Altman, Douglas G.
    Laupacis, Andreas
    Gotzsche, Peter C.
    Krleza-Jeric, Karmela
    Hrobjartsson, Asbjorn
    Mann, Howard
    Dickersin, Kay
    Berlin, Jesse A.
    Dore, Caroline J.
    Parulekar, Wendy R.
    Summerskill, William S. M.
    Groves, Trish
    Schulz, Kenneth F.
    Sox, Harold C.
    Rockhold, Frank W.
    Rennie, Drummond
    Moher, David
    [J]. ANNALS OF INTERNAL MEDICINE, 2013, 158 (03) : 200 - +
  • [6] SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
    Chan, An-Wen
    Tetzlaff, Jennifer M.
    Gotzsche, Peter C.
    Altman, Douglas G.
    Mann, Howard
    Berlin, Jesse A.
    Dickersin, Kay
    Hrobjartsson, Asbjorn
    Schulz, Kenneth F.
    Parulekar, Wendy R.
    Krleza-Jeric, Karmela
    Laupacis, Andreas
    Moher, David
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [7] Colquhoun A, 2010, CHRONIC DIS CAN, V30, P135
  • [8] Randomizing patients by family practice: sample size estimation, intracluster correlation and data analysis
    Cosby, RH
    Howard, M
    Kaczorowski, J
    Willan, AR
    Sellors, JW
    [J]. FAMILY PRACTICE, 2003, 20 (01) : 77 - 82
  • [9] DAVISON AC, 1997, BOOTSTRAP METHODS TH, pCH5
  • [10] Demers A, 2012, CMAJ, V18, P743